Navigation Links
The Oncologist Pays Tribute to Dr. Judah Folkman
Date:2/27/2008

Pioneering Discoveries Led to Angiogenesis-Inhibiting Drugs for Cancer

Treatment

DURHAM, N.C., Feb. 27 /PRNewswire/ -- The February issue of The Oncologist presents a special tribute to the late Judah Folkman, M.D. -- a legendary surgeon and researcher whose scientific insight led to the development of an entirely new class of drugs for the treatment of cancers.

Dr. Folkman was best known for his work in discovering the importance of new blood vessel formation -- a process called angiogenesis -- for the growth of cancers. His discoveries led to the development of medications called angiogenesis inhibitors, which today are among the most promising new cancer treatments. At the time of his death in January, Dr. Folkman was the Julia Dyckman Andrus Professor of Pediatric Surgery and professor of cell biology at Harvard Medical School, and Director of the Vascular Biology Program at Children's Hospital Boston.

In this month's special tribute, leading scientists and physicians share recollections honoring Dr. Folkman's scientific vision, energy, and compassion. Their essays highlight Dr. Folkman's determination in his twenty- year fight against disbelief in the possibilities of anti-angiogenesis treatment for cancer. "He was patient and persevered on the road to his goal, never neglecting the rules of good science," writes Dr. H.M. Pinedo of VUmc Cancer Center, Amsterdam.

Today, more than one million patients have received some form of angiogenesis inhibitor therapy, estimates Dr. Bruce Chabner of Harvard Medical School and Massachusetts General Hospital, and Editor-in-Chief of "The Oncologist." In addition, over a thousand laboratories are working to explore the concept further. Future research will help to clarify the best uses of angiogenesis inhibitor therapy, and to develop new medications that are more effective and safer -- and perhaps one day, useful in preventing cancers in patients at high risk.

The essayists also honor Dr. Folkman's valued skills as an educator and lecturer -- his frequent talks at scientific meetings were greeted with standing-room-only crowds and standing ovations, writes Dr. Pinedo. Dr. John E. Niederhuber, Director of the National Cancer Institute, recalls Dr. Folkman's dedication and insight as a member of the National Cancer Advisory Board: "Everyone knew that this distinguished, quiet man spoke only when there was truly something to say." Dr. C. Everett Koop, former U.S. Surgeon General, offers a tribute from the unique perspective of a former surgical tutor to Dr. Folkman.

In addition to honoring his scientific achievements, each of the authors pays tribute to Dr. Folkman's human qualities -- especially his dedication to his patients, students, professional colleagues, and family. Dr. Koop concludes, "No scientific discovery can eclipse Judah Folkman the man: creative and innovative pediatric surgeon, healer in the broadest sense of the word, compassionate physician."

The special tribute appears in the February issue of "The Oncolgist," and is available online at: http://theoncologist.alphamedpress.org/cgi/content/full/13/2/205.

About AlphaMed Press

AlphaMed Press publishes the internationally renowned journals, "Stem Cells" and "The Oncologist." "Stem Cells," now in its 26th year, is the oldest and one of the world's top-tier peer-reviewed monthly journals in the fast-paced area of stem cells and regenerative medicine. "The Oncologist," in its 13th year, is a premier peer-reviewed monthly journal dedicated to physicians entrusted with the care of cancer patients. View AlphaMed Press journals at http://www.alphamedpress.org.

Contact: George Kendall: 919-680-0011, GKendall@alphamedpress.com.


'/>"/>
SOURCE AlphaMed Press
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
2. Jefferson radiation oncologists use real-time system to plant seeds against cancer
3. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
4. Leading Oncologists from Across the Country Hold Emergency Meeting on New Government Reimbursement Policy for Medicare Patients with Cancer
5. Jefferson oncologists show focused radiation is effective as surgery against nerve tumor
6. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
7. 91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs
8. Society of Gynecologic Oncologists to Host 39th Annual Meeting on Womens Cancer
9. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
10. Adverse housing conditions contribute to diabetes risk
11. Infection contributes to the high rates of oropharyngeal cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... ... The Amnesty Rally 2017 will be held on Saturday, July 29 from 10:00 ... Monroe (adjacent to the Louisiana Purchase Gardens & Zoo). , The objective of ... can turn in unregistered, illegally-held and imitation guns to law enforcement officers without penalty ...
(Date:7/25/2017)... ... 25, 2017 , ... “Now Hiring!” is a popular phrase at Home ... achieved record-breaking sales for over 30 consecutive years and now plans to hire more ... year offers excitement and growth at HDIS, following the company’s acquisition by Fortune 1000 ...
(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, ... to communities across North Carolina, is launching a charity event in conjunction with ... for the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Gina Negrette, ... has more than a decade of experience in psychiatry, treating clients in diverse ... addictions, eating disorders, psychotic and manic conditions, as well as those who were ...
(Date:7/24/2017)... COLLEGE PARK (PRWEB) , ... July 24, 2017 , ... ... It is bio-compatible, because it produces the same kind of electrical energy that the ... in the form of moving electrons. This flow of electrons out of the battery ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 The Institute ... test methods, is the recipient of a VITROCELL® inhalation ... PETA International Science Consortium. The device, which is designed ... to expose human lung cells to airborne test materials ... will use the VITROCELL® system for testing combustible tobacco ...
(Date:7/10/2017)... 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. The ... global decision makers and innovative biotech startup companies. The ... during two impactful days. BioPharm America is now part ... networking opportunities with 4,500+ life science industry influencers participating ...
(Date:7/6/2017)... nutrition division of Diplomat Specialty Infusion Group, is celebrating a decade of ... To celebrate its anniversary, ThriveRx recently launched a redesigned website at ... organization to create the best user experience for consumers and health care ... Diplomat Pharmacy ... "We,ve made several great strides throughout the past 10 ...
Breaking Medicine Technology: